Serum Fibrosis Markers for the Diagnosis of Liver Disease Among People With Chronic Hepatitis C in Chennai, India

Serum Fibrosis Markers for the Diagnosis of Liver Disease Among People With Chronic Hepatitis C in Chennai, India

Background. Access to hepatitis C virus (HCV) treatment is limited in low- and middle-income countries (LMICs). Noninvasive biomarkers, such as fibrosis 4 (FIB-4) and aminotransferase to platelet ratio index (APRI), are low-cost alternatives to staging liver disease and identifying treatment need in...

Full description

Bibliographic Details
Main Authors: Cepeda, Javier A., Solomon, Sunil S., Srikrishnan, Aylur K., Nandagopal, Paneerselvam, Balakrishnan, Pachamuthu, Kumar, Muniratnam S., Thomas, David L., Sulkowski, Mark S., Mehta, Shruti H.
Format: Online
Language:English
Published: Oxford University Press 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047433/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047433/

Similar Items